MetaVia, Inc. (MTVA)
1.01
-0.06
(-5.61%)
USD |
NASDAQ |
Nov 20, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
MetaVia Total Liabilities (Quarterly) : 7.143M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.143M |
| June 30, 2026 | 6.449M |
| March 31, 2026 | 5.315M |
| December 31, 2025 | 63.79M |
| September 30, 2025 | 8.434M |
| June 30, 2025 | 8.835M |
| March 31, 2025 | 7.747M |
| December 31, 2024 | 8.329M |
| September 30, 2024 | 9.193M |
| June 30, 2024 | 9.809M |
| March 31, 2024 | 6.942M |
| December 31, 2023 | 6.096M |
| September 30, 2023 | 4.875M |
| June 30, 2023 | 3.983M |
| March 31, 2023 | 10.98M |
| December 31, 2022 | 11.78M |
| September 30, 2022 | 1.619M |
| June 30, 2022 | 1.249M |
| March 31, 2022 | 1.533M |
| December 31, 2021 | 2.202M |
| September 30, 2021 | 1.952M |
| June 30, 2021 | 1.241M |
| Date | Value |
|---|---|
| March 31, 2021 | 1.009M |
| December 31, 2020 | 3.765M |
| September 30, 2020 | 3.692M |
| June 30, 2020 | 3.214M |
| March 31, 2020 | 3.795M |
| December 31, 2019 | 2.176M |
| September 30, 2019 | 3.073M |
| June 30, 2019 | 2.05M |
| March 31, 2019 | 1.712M |
| December 31, 2018 | 11.92M |
| September 30, 2018 | 14.02M |
| June 30, 2018 | 13.76M |
| March 31, 2018 | 14.02M |
| December 31, 2017 | 15.08M |
| September 30, 2017 | 16.26M |
| June 30, 2017 | 5.274M |
| March 31, 2017 | 4.545M |
| December 31, 2016 | 4.122M |
| September 30, 2016 | 1.936M |
| June 30, 2016 | 14.43M |
| March 31, 2016 | 9.044M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.08M |
| Arrowhead Pharmaceuticals, Inc. | 1.759B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.554M |
| Shareholders Equity (Quarterly) | 2.411M |
| Debt to Equity Ratio | 0.0664 |
| Current Ratio | 1.284 |
| Net Debt Paydown Yield | -0.12% |